Terms: = Breast cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
62 results:
1. Discovery of an independent poor-prognosis subtype associated with tertiary lymphoid structures in breast cancer.
Liu R; Huang X; Yang S; Du W; Chen X; Li H
Front Immunol; 2024; 15():1364506. PubMed ID: 38571938
[TBL] [Abstract] [Full Text] [Related]
2. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
[TBL] [Abstract] [Full Text] [Related]
3. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
4. Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer.
Wang L; Gong S; Pang L; Zhang S; Zhang X; He W
Sci Rep; 2023 Aug; 13(1):13542. PubMed ID: 37598257
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of the Correlation and Prognostic Significance of Tertiary Lymphoid Structures in breast cancer: A Radiomics-Clinical Integration Approach.
Li K; Ji J; Li S; Yang M; Che Y; Xu Z; Zhang Y; Wang M; Fang Z; Luo L; Wu C; Lai X; Dong J; Zhang X; Zhao N; Liu Y; Wang W
J Magn Reson Imaging; 2024 Apr; 59(4):1206-1217. PubMed ID: 37526043
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy.
Wang Q; Sun K; Liu R; Song Y; Lv Y; Bi P; Yang F; Li S; Zhao J; Li X; Chen D; Mei J; Yang R; Chen K; Liu D; Tang S
Clin Transl Med; 2023 Aug; 13(8):e1346. PubMed ID: 37525587
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer associated CD169
Gunnarsdottir FB; Briem O; Lindgren AY; Källberg E; Andersen C; Grenthe R; Rosenqvist C; Millrud CR; Wallgren M; Viklund H; Bexell D; Johansson ME; Hedenfalk I; Hagerling C; Leandersson K
Front Immunol; 2023; 14():1180209. PubMed ID: 37404831
[TBL] [Abstract] [Full Text] [Related]
8. Primary breast B-cell non-Hodgkin’s lymphoma of the breast. Case Report and review of the literature.
Santiago-Sanabria L; Garza-Arrieta J; Porras-Ibarra GD; Malfavón-Farias M
Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):53-67. PubMed ID: 37093942
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia-Induced fus-circTBC1D14 Stress Granules Promote Autophagy in TNBC.
Liu Y; Liu Y; He Y; Zhang N; Zhang S; Li Y; Wang X; Liang Y; Chen X; Zhao W; Chen B; Wang L; Luo D; Yang Q
Adv Sci (Weinh); 2023 Apr; 10(10):e2204988. PubMed ID: 36806670
[TBL] [Abstract] [Full Text] [Related]
10. Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.
Deng J; Mi L; Wang X; Zhu J; Zhang C; Song Y
Hematology; 2022 Dec; 27(1):1272-1281. PubMed ID: 36476227
[TBL] [Abstract] [Full Text] [Related]
11. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K
Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236
[TBL] [Abstract] [Full Text] [Related]
12. Tumor-Infiltrating Lymphocytes (TIL), Tertiary Lymphoid Structures (tls), and Expression of PD-1, TIM-3, LAG-3 on TIL in Invasive and In Situ Ductal breast Carcinomas and Their Relationship with Prognostic Factors.
Acar E; Esendağlı G; Yazıcı O; Dursun A
Clin Breast Cancer; 2022 Dec; 22(8):e901-e915. PubMed ID: 36089459
[TBL] [Abstract] [Full Text] [Related]
13. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and prognosis of Patients With breast cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract] [Full Text] [Related]
14. CD20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
15. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and tls-ERG gene fusion: A case report.
Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
[TBL] [Abstract] [Full Text] [Related]
16. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic fus/Chemotherapy on Murine 4T1 breast cancer Cell.
Kang Z; Yang M; Feng X; Liao H; Zhang Z; Du Y
Int J Nanomedicine; 2022; 17():2165-2187. PubMed ID: 35592098
[TBL] [Abstract] [Full Text] [Related]
17. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
Giatromanolaki A; Gkegka AG; Pouliliou S; Biziota E; Kakolyris S; Koukourakis M
Breast Cancer Res Treat; 2022 Jul; 194(1):13-23. PubMed ID: 35482128
[TBL] [Abstract] [Full Text] [Related]
18. Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma.
Langendonk M; de Jong MRW; Smit N; Seiler J; Reitsma B; Ammatuna E; Glaudemans AWJM; van den Berg A; Huls GA; Visser L; van Meerten T
Blood Cancer J; 2022 Mar; 12(3):36. PubMed ID: 35256592
[TBL] [Abstract] [Full Text] [Related]
19. The circROBO1/KLF5/fus feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.
Wang Z; Yang L; Wu P; Li X; Tang Y; Ou X; Zhang Y; Xiao X; Wang J; Tang H
Mol Cancer; 2022 Jan; 21(1):29. PubMed ID: 35073911
[TBL] [Abstract] [Full Text] [Related]
20. [Role of Palliative Care in the Introduction of Chemotherapy in Patients with Poor Performance Status].
Sato I; Nakaya N; Obara Y; Kurosaka N; Ueno S; Nakajima H
Gan To Kagaku Ryoho; 2021 May; 48(5):735-737. PubMed ID: 34006726
[TBL] [Abstract] [Full Text] [Related]
[Next]